The software company named a new CEO and raised its revenue forecast for the third quarter. Alexion Pharmaceuticals Inc., up 83 cents to $116.08.
read source

The software company named a new CEO and raised its revenue forecast for the third quarter. Alexion Pharmaceuticals Inc., up 83 cents to $116.08.
read source